Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

‘Another milestone for the Genedrive platform’ says CEO David Budd

Thursday, November 17, 2016 6:14
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Genedrive PLC (LON:GDR) has received European regulatory sign-off for its rapid genotyping device for patients with hepatitis-c.

Chief executive David Budd tells Proactive: ”It’s something that we’re certainly excited about and I think another milestone in the development of our Genedrive handheld platform”.

”Today anyone trying to do this type of analysis is probably going to a speciality reference laboratory or a hospital environment to get the test done – generally they’re expensive and the turnaround time tends to be reasonably long. What we’ve demonstrated here is that we can use our Genedrive device to genotype patients and we can do that in a near patient or point-of-care setting in under an hour”.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.